Abiopharma

🔍 Clark Matthew Eliot (Executive)

Company: CHEESECAKE FACTORY INC (CAKE)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 68,900 shares of Common Stock at $40.16 per share (Direct)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 114,009.00 | transaction_form_type: 4
• Sold 68,900 shares of Common Stock at $99.3 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 45,109.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-30 | Code: H | shares_owned_after: 36,220.00 | Footnotes: F2
• Sold 68,900 shares of Employee Stock Option (Right to Buy) at $40.16 per share (Derivative)
  Date: 2026-07-30 | Code: M | Expires: 2030-02-18 | Exercise: 2021-02-18 | equity_swap_involved: 0 | transaction_form_type: 4

Footnotes:

• F1: The price reported within column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $99.05 to $99.71, inclusive. The reporting person undertakes to provide to CAKE Corporation, any security holder of CAKE Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
• F2: Shares of restricted stock subject to forfeiture.